Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
719.82B | 702.28B | 701.19B | 645.27B | 580.93B | 596.50B | Gross Profit |
254.28B | 239.00B | 242.97B | 236.89B | 212.50B | 213.34B | EBIT |
51.36B | 42.77B | 49.12B | 52.18B | 41.35B | 36.76B | EBITDA |
84.00B | 88.58B | 80.53B | 79.12B | 66.58B | 62.10B | Net Income Common Stockholders |
47.10B | 37.20B | 38.94B | 40.13B | 26.98B | 23.58B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
98.03B | 103.55B | 98.12B | 90.54B | 143.33B | 104.84B | Total Assets |
801.40B | 790.25B | 731.64B | 641.02B | 647.63B | 583.93B | Total Debt |
24.73B | 67.89B | 67.92B | 38.04B | 97.96B | 61.21B | Net Debt |
-73.30B | -35.66B | -30.20B | -52.50B | -45.37B | -43.63B | Total Liabilities |
270.64B | 279.70B | 270.55B | 227.66B | 273.93B | 242.79B | Stockholders Equity |
522.70B | 502.72B | 453.80B | 405.73B | 367.03B | 334.71B |
Cash Flow | Free Cash Flow | ||||
0.00 | 18.17B | -4.75B | 14.26B | 15.82B | 28.25B | Operating Cash Flow |
0.00 | 76.31B | 31.58B | 49.36B | 59.55B | 63.84B | Investing Cash Flow |
0.00 | -53.79B | -35.27B | -31.89B | -42.62B | -36.70B | Financing Cash Flow |
0.00 | -18.95B | 8.78B | -75.77B | 22.70B | -20.88B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $449.96B | 13.87 | 8.24% | 2.21% | 7.37% | 48.51% | |
73 Outperform | ¥330.99B | 14.87 | 2.13% | 0.15% | -10.10% | ||
66 Neutral | $582.81B | 12.46 | 9.16% | 2.74% | 3.01% | 61.47% | |
64 Neutral | ¥31.94B | 11.51 | 4.56% | -1.52% | ― | ||
63 Neutral | $4.27B | 11.40 | 5.38% | 214.63% | 4.11% | -8.98% | |
62 Neutral | $76.23B | 18.53 | 3.43% | 3.60% | 0.16% | 402.60% | |
60 Neutral | $474.75B | ― | -2.52% | 5.12% | 0.38% | -295.54% |